vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and Origin Bancorp, Inc. (OBK). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($204.6M vs $104.0M, roughly 2.0× Origin Bancorp, Inc.). Over the past eight quarters, Origin Bancorp, Inc.'s revenue compounded faster (3.9% CAGR vs 2.2%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".

INSP vs OBK — Head-to-Head

Bigger by revenue
INSP
INSP
2.0× larger
INSP
$204.6M
$104.0M
OBK
Faster 2-yr revenue CAGR
OBK
OBK
Annualised
OBK
3.9%
2.2%
INSP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
INSP
INSP
OBK
OBK
Revenue
$204.6M
$104.0M
Net Profit
$27.7M
Gross Margin
86.5%
Operating Margin
13.0%
Net Margin
26.6%
Revenue YoY
1.6%
Net Profit YoY
EPS (diluted)
$-0.39
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
OBK
OBK
Q1 26
$204.6M
$104.0M
Q4 25
$269.1M
$103.4M
Q3 25
$224.5M
$109.8M
Q2 25
$217.1M
$83.5M
Q1 25
$201.3M
$94.1M
Q4 24
$239.7M
$78.3M
Q3 24
$203.2M
$90.8M
Q2 24
$195.9M
$96.4M
Net Profit
INSP
INSP
OBK
OBK
Q1 26
$27.7M
Q4 25
$136.1M
$29.5M
Q3 25
$9.9M
$8.6M
Q2 25
$-3.6M
$14.6M
Q1 25
$3.0M
$22.4M
Q4 24
$35.2M
$14.3M
Q3 24
$18.5M
$18.6M
Q2 24
$9.8M
$21.0M
Gross Margin
INSP
INSP
OBK
OBK
Q1 26
86.5%
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Operating Margin
INSP
INSP
OBK
OBK
Q1 26
13.0%
Q4 25
17.1%
36.2%
Q3 25
4.3%
10.0%
Q2 25
-1.5%
22.3%
Q1 25
-0.7%
30.4%
Q4 24
13.3%
23.0%
Q3 24
7.0%
26.1%
Q2 24
2.6%
27.7%
Net Margin
INSP
INSP
OBK
OBK
Q1 26
26.6%
Q4 25
50.6%
28.5%
Q3 25
4.4%
7.9%
Q2 25
-1.7%
17.5%
Q1 25
1.5%
23.8%
Q4 24
14.7%
18.2%
Q3 24
9.1%
20.5%
Q2 24
5.0%
21.8%
EPS (diluted)
INSP
INSP
OBK
OBK
Q1 26
$-0.39
$0.89
Q4 25
$4.57
$0.95
Q3 25
$0.34
$0.27
Q2 25
$-0.12
$0.47
Q1 25
$0.10
$0.71
Q4 24
$1.17
$0.45
Q3 24
$0.60
$0.60
Q2 24
$0.32
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
OBK
OBK
Cash + ST InvestmentsLiquidity on hand
$98.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$792.3M
$1.3B
Total Assets
$911.4M
$10.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
OBK
OBK
Q1 26
$98.9M
Q4 25
$308.3M
$424.2M
Q3 25
$322.6M
$626.9M
Q2 25
$300.9M
$334.1M
Q1 25
$369.2M
$486.2M
Q4 24
$445.5M
$470.2M
Q3 24
$411.0M
$321.2M
Q2 24
$439.7M
$288.1M
Stockholders' Equity
INSP
INSP
OBK
OBK
Q1 26
$792.3M
$1.3B
Q4 25
$781.2M
$1.2B
Q3 25
$666.5M
$1.2B
Q2 25
$677.8M
$1.2B
Q1 25
$635.7M
$1.2B
Q4 24
$689.7M
$1.1B
Q3 24
$696.6M
$1.1B
Q2 24
$638.1M
$1.1B
Total Assets
INSP
INSP
OBK
OBK
Q1 26
$911.4M
$10.2B
Q4 25
$907.3M
$9.7B
Q3 25
$807.7M
$9.8B
Q2 25
$802.2M
$9.7B
Q1 25
$730.8M
$9.8B
Q4 24
$808.4M
$9.7B
Q3 24
$796.2M
$10.0B
Q2 24
$728.4M
$9.9B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSP
INSP

Segment breakdown not available.

OBK
OBK

Net Interest Income$87.2M84%
Noninterest Income$16.8M16%

Related Comparisons